Document ID: FDA-2011-N-0002-0100
Agency: fda
Document Type: Notice
Title: Request for Nominations for Voting Members on a Public Advisory Committee; Tobacco Products Scientific Advisory Committee
Posted Date: 2011-09-02T04:00Z

[Federal Register Volume 76, Number 171 (Friday, September 2, 2011)]
[Notices]
[Pages 54777-54778]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-22548]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0002]

Request for Nominations for Voting Members on a Public Advisory 
Committee; Tobacco Products Scientific Advisory Committee

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is requesting 
nominations for members to serve on the Tobacco Products Scientific 
Advisory Committee, Center for Tobacco Products.
    FDA has a special interest in ensuring that women, minority groups, 
and individuals with disabilities are adequately represented on 
advisory committees and, therefore, encourages nominations of qualified 
candidates from these groups.

DATES: Nominations received on or before November 1, 2011 will be given 
first consideration for membership on the Tobacco Products Scientific 
Advisory Committee. Nominations received after November 1, 2011 will be 
considered for nomination to the committee if nominees are still 
needed.

ADDRESSES: All nominations for membership should be sent electronically 
to cv@oc.fda.gov, or by mail to Advisory Committee Oversight and 
Management Staff, 10903 New Hampshire Ave., Bldg. 32, Rm. 5103, Silver 
Spring, MD 20993-0002.

FOR FURTHER INFORMATION CONTACT:
    Regarding all nomination questions for membership, the primary 
contact is:
    Caryn Cohen, Office of Science, Center for Tobacco Products, Food 
and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 1-
877-287-1373 (choose Option 4), FAX: 240-276-3761, TPSAC@fda.hhs.gov.

[[Page 54778]]

    Information about becoming a member on an FDA advisory committee 
can also be obtained by visiting FDA's Web site by using the following 
link: http://www.fda.gov/AdvisoryCommittees/default.htm.

SUPPLEMENTARY INFORMATION: FDA is requesting nomination for voting 
members on the Tobacco Products Scientific Advisory Committee.

I. General Description of the Committee Duties

    The Tobacco Products Scientific Advisory Committee (the Committee) 
advises the Commissioner of Food and Drugs (the Commissioner) or 
designee in discharging responsibilities as they relate to the 
regulation of tobacco products. The Committee reviews and evaluates 
safety, dependence, and health issues relating to tobacco products and 
provides appropriate advice, information and recommendations to the 
Commissioner.

II. Criteria for Voting Members

    Members and the Chair are selected by the Commissioner or designee 
from among individuals knowledgeable in the fields of medicine, medical 
ethics, science, or technology involving the manufacture, evaluation, 
or use of tobacco products. Members will be invited to serve for terms 
of up to 4 years. The Committee shall include nine technically 
qualified voting members, selected by the Commissioner or designee. The 
nine voting members shall be physicians, dentists, scientists, or 
health care professionals practicing in the area of oncology, 
pulmonology, cardiology, toxicology, pharmacology, addiction, or any 
other relevant specialty.

III. Nomination Procedures

    Any interested person may nominate one or more qualified 
individuals for membership on the advisory committee. Self-nominations 
are also accepted. Nominations must include a current, complete resume 
or curriculum vitae for each nominee, including current business 
address and/or home address, telephone number, and e-mail address if 
available. Nominations must also specify the advisory committee for 
which the nominee recommended. Nomination must also acknowledge that 
the nominee is aware of the nomination unless self-nominated. FDA will 
ask potential candidates to provide detailed information concerning 
such matters related to financial holdings, employment, and research 
grants and/or contracts to permit evaluation of possible sources of 
conflicts of interest.
    This notice is issued under the Federal Advisory Committee Act (5 
U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees.

    Dated: August 30, 2011.
Jill Hartzler Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2011-22548 Filed 9-1-11; 8:45 am]
BILLING CODE 4160-01-P